OBJECTIVES: To examine the association between retinal microvascular signs, as a proxy for cerebral microvascular disease, and cognitive impairment. DESIGN: Cross-sectional population-based study. SETTING: Urban population survey PARTICIPANTS: One thousand nine hundred eighty-eight persons aged 49 to 97. MEASUREMENTS: All participants underwent retinal photography and had the Mini-Mental State Examination (MMSE) administered by trained personnel. Retinal photographs were masked and graded for retinopathy signs (microaneurysms, hemorrhages, hard exudates, cotton wool spots), and retinal vessel calibers were measured using a validated computer-assisted method. Cognitive impairment was defined as an MMSE score of 23 or less, in line with other epidemiological studies. RESULTS: Cognitive impairment was present in 121 participants (6.1%). In the total population, after adjusting for age, sex, blood pressure, diabetes mellitus, smoking, cardiovascular disease, education, and other factors, retinal venular dilation was associated with cognitive impairment (odds ratio (OR)=1.8, 95% confidence interval (95% CI)=1.0-3.2, P=.03). In persons with hypertension, retinopathy signs (adjusted OR=1.7, 95% CI=1.0-3.2, P=.05) and retinal venular dilation (adjusted OR=2.7, 95% CI=1.2-6.1, P=.01) were associated with cognitive impairment. CONCLUSION: Retinal microvascular signs are associated with significant cognitive impairment, particularly in older persons with hypertension. These findings suggest that cerebral microvascular changes may contribute to cognitive deterioration.
OBJECTIVES: To examine the association between retinal microvascular signs, as a proxy for cerebral microvascular disease, and cognitive impairment. DESIGN: Cross-sectional population-based study. SETTING: Urban population survey PARTICIPANTS: One thousand nine hundred eighty-eight persons aged 49 to 97. MEASUREMENTS: All participants underwent retinal photography and had the Mini-Mental State Examination (MMSE) administered by trained personnel. Retinal photographs were masked and graded for retinopathy signs (microaneurysms, hemorrhages, hard exudates, cotton wool spots), and retinal vessel calibers were measured using a validated computer-assisted method. Cognitive impairment was defined as an MMSE score of 23 or less, in line with other epidemiological studies. RESULTS:Cognitive impairment was present in 121 participants (6.1%). In the total population, after adjusting for age, sex, blood pressure, diabetes mellitus, smoking, cardiovascular disease, education, and other factors, retinal venular dilation was associated with cognitive impairment (odds ratio (OR)=1.8, 95% confidence interval (95% CI)=1.0-3.2, P=.03). In persons with hypertension, retinopathy signs (adjusted OR=1.7, 95% CI=1.0-3.2, P=.05) and retinal venular dilation (adjusted OR=2.7, 95% CI=1.2-6.1, P=.01) were associated with cognitive impairment. CONCLUSION: Retinal microvascular signs are associated with significant cognitive impairment, particularly in older persons with hypertension. These findings suggest that cerebral microvascular changes may contribute to cognitive deterioration.
Authors: F J de Jong; E M C Schrijvers; M K Ikram; P J Koudstaal; P T V M de Jong; A Hofman; J R Vingerling; M M B Breteler Journal: Neurology Date: 2011-02-02 Impact factor: 9.910
Authors: C Qiu; M F Cotch; S Sigurdsson; P V Jonsson; M K Jonsdottir; S Sveinbjrnsdottir; G Eiriksdottir; R Klein; T B Harris; M A van Buchem; V Gudnason; L J Launer Journal: Neurology Date: 2010-12-14 Impact factor: 9.910
Authors: J Ding; M W J Strachan; F G R Fowkes; T Y Wong; T J Macgillivray; N Patton; T A Gardiner; I J Deary; J F Price Journal: Diabetologia Date: 2011-04-01 Impact factor: 10.122
Authors: Daniel W Belsky; Avshalom Caspi; Renate Houts; Harvey J Cohen; David L Corcoran; Andrea Danese; HonaLee Harrington; Salomon Israel; Morgan E Levine; Jonathan D Schaefer; Karen Sugden; Ben Williams; Anatoli I Yashin; Richie Poulton; Terrie E Moffitt Journal: Proc Natl Acad Sci U S A Date: 2015-07-06 Impact factor: 11.205
Authors: Jie Ding; Mark W J Strachan; Rebecca M Reynolds; Brian M Frier; Ian J Deary; F Gerald R Fowkes; Amanda J Lee; Janet McKnight; Patricia Halpin; Ken Swa; Jackie F Price Journal: Diabetes Date: 2010-08-26 Impact factor: 9.461
Authors: Sophie M Heringa; Willem H Bouvy; Esther van den Berg; Annette C Moll; L Jaap Kappelle; Geert Jan Biessels Journal: J Cereb Blood Flow Metab Date: 2013-04-17 Impact factor: 6.200
Authors: Kristine Yaffe; Lynn Ackerson; Tina D Hoang; Alan S Go; Maureen G Maguire; Gui-Shuang Ying; Ebenezer Daniel; Lydia A Bazzano; Martha Coleman; Debbie L Cohen; John W Kusek; Akinlolu Ojo; Stephen Seliger; Dawei Xie; Juan E Grunwald Journal: Am J Kidney Dis Date: 2012-12-01 Impact factor: 8.860